Another paper confirmed that the loss of ARID1A expression, a surrogate for ARID1A mutations, has been reported in one-third of these tumors, a frequency similar to that seen in ovarian endometrioid carcinomas, supporting their close relationship [10]. Here, ARID1A is linked to ovarian endometrioid carcinoma.